Common Equity: The sum of all common equity items.
Psyence Biomedical Ltd. (PBM) had Common Equity of $16.94M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-6.94M |
|
-- |
|
-- |
|
$6.24M |
|
$-6.24M |
|
$-0.70M |
|
$-6.94M |
|
$-6.94M |
|
$-6.94M |
|
$-6.94M |
|
$-6.94M |
|
$-6.94M |
|
$-6.24M |
|
$-6.23M |
|
0.55M |
|
0.55M |
|
$-12.56 |
|
$-12.56 |
|
| Balance Sheet Financials | |
$9.11M |
|
$0.01M |
|
$8.46M |
|
$17.57M |
|
$0.62M |
|
-- |
|
-- |
|
$0.62M |
|
|
Common Equity |
$16.94M |
$16.94M |
|
$16.94M |
|
2.29M |
|
| Cash Flow Statement Financials | |
$-8.14M |
|
$-4.51M |
|
$13.96M |
|
$6.14M |
|
$7.44M |
|
$1.31M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.94% |
|
-40.94% |
|
-39.48% |
|
-40.94% |
|
$7.39 |
|
$-14.74 |
|
$-14.74 |
|